EAST PROVIDENCE, R.I. (WPRI) — It's being considered a breakthrough in the war on Alzheimer's.

The results of the U.S. POINTER clinical trial, conducted right here in Rhode Island, were announced on July 28 at the Alzheimer's Association National Conference in Toronto.

The principal investigator of the study, Dr. Stephen Salloway, and study participant Linda Pietras of Providence, joined 12 News Anchor Shannon Hegy on this week's 12 Health to dive further into those results.

The two-year clinical trial evaluated whether lifestyle interventions — exercise, a Mediterranean diet, heart health, and brain stimulation training — could protect cognitive function for older adults at high risk of dementia and Alzheimer's. Study participants were ages 60 to 79 and had a number of risk factors, in

See Full Page